Literature DB >> 32846056

Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.

Moncef Slaoui1, Matthew Hepburn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32846056     DOI: 10.1056/NEJMp2027405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  38 in total

1.  A government-led effort to identify correlates of protection for COVID-19 vaccines.

Authors:  Richard A Koup; Ruben O Donis; Peter B Gilbert; Andrew W Li; Najaf A Shah; Christopher R Houchens
Journal:  Nat Med       Date:  2021-09       Impact factor: 87.241

2.  Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.

Authors:  Stephen R Hanney; Sharon E Straus; Bev J Holmes
Journal:  Health Res Policy Syst       Date:  2022-09-10

Review 3.  Engineering synthetic RNA devices for cell control.

Authors:  Peter B Dykstra; Matias Kaplan; Christina D Smolke
Journal:  Nat Rev Genet       Date:  2022-01-04       Impact factor: 59.581

Review 4.  Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope.

Authors:  Arun Kumar; Asmita Deka Dey; Tapan Behl; Swati Chadha; Vishal Aggarwal
Journal:  Int Immunopharmacol       Date:  2020-11-03       Impact factor: 4.932

5.  RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should Know.

Authors:  Chien-Jung Lin; Robert P Mecham; Douglas L Mann
Journal:  JACC Basic Transl Sci       Date:  2020-11-23

6.  SARS-CoV-2 vaccine development, access, and equity.

Authors:  Jerome H Kim
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

7.  Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).

Authors:  Andrew P Ambrosy; Umar I Malik; Rachel C Thomas; Rishi V Parikh; Thida C Tan; Choon H Goh; Van N Selby; Matthew D Solomon; Harshith R Avula; Jesse K Fitzpatrick; Jacek Skarbinski; Sephy Philip; Craig Granowitz; Deepak L Bhatt; Alan S Go
Journal:  Am Heart J       Date:  2021-01-28       Impact factor: 4.749

8.  US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.

Authors:  Rafael Dal-Ré
Journal:  Vaccine       Date:  2021-01-20       Impact factor: 3.641

Review 9.  Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.

Authors:  Steven Joffe; Abdel Babiker; Susan S Ellenberg; Alan Fix; Marie R Griffin; Sally Hunsberger; Jorge Kalil; Myron M Levine; Malegapuru W Makgoba; Reneé H Moore; Anastasios A Tsiatis; Richard Whitley
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

10.  [Active vaccinations : One of the essential measures to maintain the health of our patients with rheumatic diseases].

Authors:  H-I Huppertz; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2020-11-06       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.